Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus.

MLA

De Matteis, Arianna, et al. “Tocilizumab for Massive Refractory Pleural Effusion in an Adolescent with Systemic Lupus Erythematosus.” Pediatric Rheumatology Online Journal, vol. 19, no. 1, Sept. 2021, p. 144. EBSCOhost, https://doi.org/10.1186/s12969-021-00635-w.

APA

De Matteis, A., Sacco, E., Celani, C., Uva, A., Messia, V., Nicolai, R., Pardeo, M., De Benedetti, F., & Bracaglia, C. (2021). Tocilizumab for massive refractory pleural effusion in an adolescent with systemic lupus erythematosus. Pediatric Rheumatology Online Journal, 19(1), 144. https://doi.org/10.1186/s12969-021-00635-w

Chicago

De Matteis, Arianna, Emanuela Sacco, Camilla Celani, Andrea Uva, Virginia Messia, Rebecca Nicolai, Manuela Pardeo, Fabrizio De Benedetti, and Claudia Bracaglia. 2021. “Tocilizumab for Massive Refractory Pleural Effusion in an Adolescent with Systemic Lupus Erythematosus.” Pediatric Rheumatology Online Journal 19 (1): 144. doi:10.1186/s12969-021-00635-w.